Vanguard Group’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Buy |
1,401,693
+183,322
| +15% | +$1.75M | ﹤0.01% | 2750 |
|
|
2025
Q1 | $11.3M | Buy |
1,218,371
+10,606
| +0.9% | +$98.6K | ﹤0.01% | 2774 |
|
|
2024
Q4 | $16.8M | Sell |
1,207,765
-37,643
| -3% | -$523K | ﹤0.01% | 2669 |
|
|
2024
Q3 | $29.3M | Buy |
1,245,408
+6,907
| +0.6% | +$162K | ﹤0.01% | 2408 |
|
|
2024
Q2 | $19.8M | Buy |
1,238,501
+338,701
| +38% | +$5.42M | ﹤0.01% | 2574 |
|
|
2024
Q1 | $14.8M | Buy |
899,800
+140,833
| +19% | +$2.31M | ﹤0.01% | 2750 |
|
|
2023
Q4 | $10.5M | Buy |
758,967
+26,383
| +4% | +$365K | ﹤0.01% | 2918 |
|
|
2023
Q3 | $10.1M | Buy |
732,584
+83,709
| +13% | +$1.15M | ﹤0.01% | 2871 |
|
|
2023
Q2 | $11.1M | Buy |
648,875
+9,551
| +1% | +$163K | ﹤0.01% | 2888 |
|
|
2023
Q1 | $10.3M | Buy |
639,324
+34,957
| +6% | +$562K | ﹤0.01% | 2921 |
|
|
2022
Q4 | $4.59M | Buy |
604,367
+4,414
| +0.7% | +$33.5K | ﹤0.01% | 3343 |
|
|
2022
Q3 | $5.27M | Buy |
599,953
+8,844
| +1% | +$77.7K | ﹤0.01% | 3297 |
|
|
2022
Q2 | $4.23M | Buy |
591,109
+75,472
| +15% | +$540K | ﹤0.01% | 3465 |
|
|
2022
Q1 | $5.52M | Sell |
515,637
-846
| -0.2% | -$9.05K | ﹤0.01% | 3480 |
|
|
2021
Q4 | $7.27M | Buy |
+516,483
| New | +$7.27M | ﹤0.01% | 3408 |
|